US › Healthcare

MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

US · Healthcare · Drug Manufacturers - General

$0.63-3.95%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.2M

EPS

$-0.03

Key statistics

Market cap

$28.7M

Forward P/E

0.0

P/B

4.42

Book value

$0.19

EPS (TTM)

$-1.18

52-week high

$1.83

52-week low

$0.60

50-day MA

$0.77

200-day MA

$1.02

Beta

1.49

Analyst view

Analysts rate MIRA Pharmaceuticals, Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.50.

Shareholding

Insiders

30.58%

Institutions

5.42%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.79%
Cross Staff Investments Inc	0.86%
Geode Capital Management, LLC	0.72%
BlackRock Inc	0.58%
Vanguard Fiduciary Trust Co	0.41%
CapTrust Financial Advisors	0.22%
Northern Trust Corp	0.16%
First American Bank/Carpentersville IL	0.14%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MIRA Pharmaceuticals, Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.